Crossmark

CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia

Crossref DOI link: https://doi.org/10.1186/s13287-017-0620-4

Published Online: 2017-08-01

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lu, Shihong

Ge, Meili

Zheng, Yizhou

Li, Jianping

Feng, Xiaoming

Feng, Sizhou

Huang, Jinbo

Feng, Ying

Yang, Donglin

Shi, Jun

Chen, Fang

Han, Zhongchao
Funding

Funding for this research was provided by:

National Basic Research Program of China (2011CB964800, 2015CB964402)

National Natural Science Foundation of China (2013-81330015, 2014-81300388)

CAMS Initiative for Innovative Medicine (CAMS)